N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice

Clinical Cancer Research

Volumn 13, Issue 19, 2007, Pages 5952-5958

  Cotter, Murray A ^a   Thomas, Joshua ^b   Cassidy, Pamela ^a,b   Robinette, Kyle ^b   Jenkins, Noah ^a   Florell, Scott R ^a,b   Leachman, Sancy ^a,b   Samlowski, Wolfram E ^a,b   Grossman, Douglas ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ACETYLCYSTEINE; GLUTATHIONE; PEROXIDE; SCATTER FACTOR; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; MALE; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ACETYLCYSTEINE; ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; MALE; MELANOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, RADIATION-INDUCED; OXIDATIVE STRESS; PYRIMIDINE DIMERS; REACTIVE OXYGEN SPECIES; SKIN; ULTRAVIOLET RAYS;

EID: 35348891489     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1187     Document Type: Article

References (37)

1. Miller AJ, Mihm MC, Jr. Melanoma. N Engl J Med 2006;355:51-65.
2. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;351:998-1012.
3. Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat 2007;28:578-88.
4. Demierre MF. Epidemiology and prevention of cutaneous melanoma. Curr Treat Options Oncol 2006;7:181-6.
5. Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J. UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem 1997;378:1247-57.
6. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006;126:2565-75.
7. Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001;144:55-65.
8. Urabe K, Aroca P, Tsukamoto K, et al. The inherent cytotoxicity of melanin precursors: a revision. Biochim Biophys Acta 1994;1221:272-8.
9. Farmer PJ, Gidanian S, Shahandeh B, Di Bilio AJ, Tohidian N, Meyskens FL, Jr. Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res 2003;16:273-9.
10. Sander CS, Hamm F, Elsner P, Thiele JJ. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003;148:913-22.
11. de Souza GA, Godoy LM, Teixeira VR, et al. Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics 2006;6:1460-70.
12. Meyskens FL, Jr., Farmer PJ, Anton-Culver H. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 2004;10:2581-3.
13. Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
14. Physician's desk reference (PDR). 2007. p. 1031-4.
15. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42.
16. D'Agostini F, Balansky RM, Camoirano A, De Flora S. Modulation of light-induced skin tumors by N-acetylcysteine and/or ascorbic acid in hairless mice. Carcinogenesis 2005;26:657-64.
17. Kang S, Chung JH, Lee JH, et al. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo. J Invest Dermatol 2003;120:835-41.
18. Redondo P, Bandres E, Solano T, Okroujnov I, Garcia-Foncillas J. Vascular endothelial growth factor (VEGF) and melanoma. N-acetylcysteine downregulates VEGF production in vitro. Cytokine 2000;12:374-8.
19. Morini M, Cai T, Aluigi MG, et al. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 1999;14:268-71.
20. Thomas J, Liu T, Cotter M, et al. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF transgenic mice. Cancer Res 2007;67:5172-8.
21. Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987;39:414-8.
22. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
23. Diedrich MJ, Warters RL, Grossman D. Amifostine aminothiols and protection of keratinocyte apoptosis and DNA damage. J Invest Dermatol 2002;119:707-8.
24. Mori T, Nakane M, Hattori T, Matsunaga T, Ihara M, Nikaido O. Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4)photoproduct from the same mouse immunized with ultraviolet-irradiated DNA. Photochem Photobiol 1991;54:225-32.
25. Grossman D, McNiff JM, Li F, Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-81.
26. Takayama H, La Rochelle WJ, Anver M, Bockman DE, Merlino G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A 1996;93:5866-71.
27. Florell S, Thomas J, Grossman D. Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in HGF (C57BL/6 x C3H)F1 mice following neonatal UV irradiation. J Cutan Pathol 2007;34:667-74.
28. Dominick PK, Cassidy PB, Roberts JC. A new and versatile method for determination of thiolamines of biological importance. J Chromatogr B Biomed Sci Appl 2001;761:1-12.
29. Yim CY, Hibbs JB, Jr., McGregor JR, Galinsky RE, Samlowski WE. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol 1994;152:5796-805.
30. Sastre J, Asensi M, Rodrigo F, Pallardo FV, Vento M, Vina J. Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sci 1994;54:2055-9.
31. Korytowski W, Hintz P, Sealy RC, Kalyanaraman B. Mechanism of dismutation of superoxide produced during autoxidation of melanin pigments. Biochem Biophys Res Commun 1985;131:659-65.
32. Francis SO, Mahlberg MJ, Johnson KR, Ming ME, Dellavalle RP. Melanoma chemoprevention. J Am Acad Dermatol 2006;55:849-61.
33. Taniguchi S, Fujiki H, Kobayashi H, et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992;65:51-4.
34. Blumberg J, Block G. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland. Nutr Rev 1994;52:242-5.
35. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
36. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82.
37. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57.